Timing is Everything: Biotech Pioneers Push Follow-On Biologics Proposal

Once unthinkable, the pioneer biotech firms are jumping in with their own proposals for an abbreviated follow-on biologics regulatory pathway. They recognize that this may be the best time for many years to get a system that builds in rigorous tests for follow-ons.